GPT and metabolic dysfunction-associated steatotic liver disease: Clinical trials involving curcumin treatment in MASLD patients showed that hepatic fat fraction and blood transaminases (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)), as well as specific inflammatory markers, were significantly decreased after curcumin intervention [75,76,77,78].